- Home
- DRTS vs EOD Comparison
DRTS vs EOD Comparison
Compare DRTS & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- EOD
- Stock Information
- Founded
- DRTS 2015
- EOD 2007
- Country
- DRTS Israel
- EOD United States
- Employees
- DRTS N/A
- EOD N/A
- Industry
- DRTS Medical/Dental Instruments
- EOD Investment Managers
- Sector
- DRTS Health Care
- EOD Finance
- Exchange
- DRTS Nasdaq
- EOD Nasdaq
- Market Cap
- DRTS 274.0M
- EOD 235.6M
- IPO Year
- DRTS N/A
- EOD N/A
- Fundamental
- Price
- DRTS $3.06
- EOD $5.59
- Analyst Decision
- DRTS Strong Buy
- EOD
- Analyst Count
- DRTS 2
- EOD 0
- Target Price
- DRTS $8.00
- EOD N/A
- AVG Volume (30 Days)
- DRTS 41.1K
- EOD 118.1K
- Earning Date
- DRTS 08-13-2025
- EOD 01-01-0001
- Dividend Yield
- DRTS N/A
- EOD 9.28%
- EPS Growth
- DRTS N/A
- EOD N/A
- EPS
- DRTS N/A
- EOD N/A
- Revenue
- DRTS N/A
- EOD N/A
- Revenue This Year
- DRTS N/A
- EOD N/A
- Revenue Next Year
- DRTS N/A
- EOD N/A
- P/E Ratio
- DRTS N/A
- EOD N/A
- Revenue Growth
- DRTS N/A
- EOD N/A
- 52 Week Low
- DRTS $1.93
- EOD $3.73
- 52 Week High
- DRTS $4.39
- EOD $4.71
- Technical
- Relative Strength Index (RSI)
- DRTS 49.92
- EOD 68.19
- Support Level
- DRTS $2.95
- EOD $5.48
- Resistance Level
- DRTS $3.15
- EOD $5.51
- Average True Range (ATR)
- DRTS 0.14
- EOD 0.05
- MACD
- DRTS -0.02
- EOD 0.00
- Stochastic Oscillator
- DRTS 27.50
- EOD 95.45
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.